Hematology
News
Adding venetoclax improves ibrutinib outcomes in CLL
A small study yields sanguine news about a combination treatment, as hematologists await phase 3 results.
News
High cost and demand for old cancer drug sparks crisis
Experts have voiced alarm at the scarcity and cost of fludarabine, an old drug deemed crucial to cellular therapy for leukemia.
News
FDA approves first gene therapy for hemophilia B
The gene therapy will cost $3.5 million, making it the most expensive treatment to date.
Article
Leukocytoclastic Vasculitis Masquerading as Chronic ITP
Idiopathic thrombocytopenic purpura (ITP) and leukocytoclastic vasculitis (LCV) can present in a similar fashion and can be very hard to...
Conference Coverage
I am not fine: The heavy toll cancer takes
“I thought I was as exhausted, and isolated, and neglected as I could get, and then he came home.”
News
CAR T-cell therapy neurotoxicity linked to NfL elevations
Even prior to CAR T-cell therapy, patients developing related neurotoxic complications show elevated markers of neuronal injury.
Clinical Topics & News
Death Cafe in Hematology Oncology
Conference Coverage
Blood test for multiple cancers: Many false positives
“This technology is not ready for population-wide screening, but as the technology improves, costs will go down.”
